To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
Within the Institute, the "Funding Research and Technology Transfer" team is at your disposal to identify the scientists and the skills you need to set up a joint project, to define the terms of a collaboration contract or study.
Whether you are an academic, a SME or an industrialist, our team informs and advices you about the possibilities of consortium assembly, technology transfer, patent licensing or use of our platforms.
The team is also at the disposal of the researchers of the institute to accompany them in achieving their valorization objectives.
All the news of the Institute of life sciences Frédéric Joliot
Laboratory | Simulation ＆ modelling | Molecular mechanisms
Caveolin-1, a small membrane protein (21 KDa) plays a key role in the formation of caveolae defined from a morphological point of view as plasma membrane invaginations. These membrane structures are implicated in numerous cellular functions such as endocytosis, signalization, lipid transport and more recently mechanical stress. Our objective is to establish the molecular basis of the interactions networks associated with proteins and lipids in order to understand how the different networks of protein-lipid interactions are organized within these structures.
In addition to transversal heterogenity, cell membranes present lateral heterogeneity due non-homogeneously distribution of proteins and lipids within the membrane plane. Transversal and lateral heterogeneity are interdependent. Portions of membranes with distinct composition from the rest of the plasma membrane are named membrane domains. These domains, depending on their composition, have different physical and chemical properties, such as thickness, elasticity, long or short chains saturated lipids, cholesterol, protein crowding, etc... and thus different functionnal roles. Caveolae are « stable » membrane domains enriched in Caveolin-1, Cavins, and specific lipids such as cholesterol. Caveolin-1 is a small monotopic membrane protein found at the plasma membrane in caveolae and non-caveolae domains as caveolin-1 oligomers. It is a key structural protein of caveolae as it possesses the intrinsic properties to curve its membrane. The complex assemblies of caveolin-1 and lipids at the plasma membrane represent a challenge for the understanding of the molecular and functionnal properties of caveolin-1.
In that context, we aim at understanding the relationship between the original amino acid sequence of Caveolin-1 and its properties of oligomerization and shaping the membrane at a molecular level. For that purpose, we have produced and characterized assemblies of caveolin-1 fragments and detergent by high resolution magnetic resonance spectroscopy and modelisation, and we are now pursuing our work using Caveolin-1b , fragments and mutants assemblies with different detergents and lipids using a range of biophysical techniques.
The overexpression of Caveolin-1β can produce intracellular membrane vesicles called heterologous caveolae (h-caveolae) in the host organisms. We have observed this production in Escherichia coli bacteria and in the Sf21 insect cells, and we propose to produce membrane protein-enriched vesicles using the ability of Caveolin 1β to generate membrane vesicles within the cytoplasm in various hosts. As a proof of concept, we have chosen to co-express with Caveolin-1β the human microsomal glutathione S-transferase (hMGST1) in Escherichia coli and in the Sf21 insect cells. hMGST1 belongs to the membrane-associated proteins in eicosanoid and glutathione metabolism (MAPEG) family of integral MPs and catalyze glutathione-dependent modifications of lipophilic substrates present in the lipid membranes. hMGST1 is highly abundant in liver, and displays a noticeable role in xenobiotic detoxification, including some cytotoxic drugs.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.